A_DT
novel_JJ
growth-factor-dependent_JJ
myeloid_JJ
cell_NN
line_NN
derived_VBN
from_IN
mouse_NN
bone_NN
marrow_NN
cells_NNS
contains_VBZ
progenitors_NNS
endowed_JJ
with_IN
high_JJ
proliferative_JJ
potential_NN
._.

Constitutive_JJ
expression_NN
of_IN
human_JJ
colony-stimulating_JJ
factor-1_NN
receptor_NN
-LRB-_-LRB-
CSF-1R_NN
-RRB-_-RRB-
confers_VBZ
long-lasting_JJ
CSF-1-dependent_JJ
proliferation_NN
to_TO
mouse_NN
myeloid_JJ
cell_NN
lines_NNS
._.

We_PRP
developed_VBD
mice_NNS
transgenic_JJ
for_IN
human_JJ
CSF-1R_NN
because_IN
mouse_NN
CSF-1_NN
can_MD
not_RB
activate_VB
human_JJ
CSF-1R_NN
._.

Then_RB
bone_NN
marrow_NN
cells_NNS
from_IN
transgenic_JJ
mice_NNS
were_VBD
plated_VBN
onto_IN
MS-5_NN
stromal_JJ
cells_NNS
expressing_VBG
the_DT
membrane_NN
form_NN
of_IN
human_JJ
CSF-1_NN
-LRB-_-LRB-
2M-1_NN
cells_NNS
-RRB-_-RRB-
in_IN
order_NN
to_TO
combine_VB
the_DT
hematopoietic_JJ
supporting_NN
properties_NNS
of_IN
stromal_JJ
cells_NNS
and_CC
the_DT
proliferative_JJ
effects_NNS
of_IN
CSF-1_NN
._.

Thus_RB
,_,
we_PRP
were_VBD
able_JJ
to_TO
derive_VB
a_DT
hematopoietic_JJ
cell_NN
line_NN
,_,
called_VBN
47.10_CD
,_,
that_WDT
grew_VBD
indefinitely_RB
under_IN
these_DT
conditions_NNS
,_,
whereas_IN
no_DT
cell_NN
line_NN
could_MD
be_VB
developed_VBN
from_IN
nontransgenic_JJ
mice_NNS
._.

Proliferation_NN
of_IN
47.10_CD
cells_NNS
is_VBZ
severely_RB
affected_VBN
by_IN
neutralizing_VBG
anti-CSF-1R_JJ
monoclonal_JJ
antibodies_NNS
._.

Morphologic_JJ
and_CC
cytofluorometry_JJ
analysis_NN
established_VBD
that_IN
most_JJS
47.10_CD
cells_NNS
are_VBP
immature_JJ
myelomonocytic_JJ
cells_NNS
._.

Consistent_JJ
with_IN
this_DT
phenotype_NN
,_,
the_DT
myeloid_JJ
transcription_NN
factor_NN
PU_NN
.1_CD
,_,
but_CC
not_RB
the_DT
erythroid_JJ
transcription_NN
factor_NN
GATA-1_NN
,_,
is_VBZ
expressed_VBN
in_IN
47.10_CD
cells_NNS
._.

A_DT
few_JJ
47.10_CD
cells_NNS
-LRB-_-LRB-
3-5_CD
%_NN
-RRB-_-RRB-
do_VBP
not_RB
express_VB
lineage_NN
specific_JJ
markers_NNS
;_:
they_PRP
differentiate_VBP
spontaneously_RB
to_TO
lineage-positive_JJ
cells_NNS
after_IN
replating_VBG
on_IN
2M-1_NN
cells_NNS
._.

In_IN
agar_NN
cultures_NNS
,_,
47.10_CD
cells_NNS
form_VBP
7_CD
-_JJ
and_CC
14-day_JJ
colonies_NNS
in_IN
response_NN
to_TO
a_DT
cocktail_NN
of_IN
granulocyte\/macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
2.5_CD
ng\/mL_NN
-RRB-_-RRB-
,_,
interleukin-3_NN
-LRB-_-LRB-
1_CD
ng\/mL_NN
-RRB-_-RRB-
,_,
and_CC
mouse_NN
CSF-1_NN
-LRB-_-LRB-
10_CD
ng\/mL_NN
-RRB-_-RRB-
._.

Under_IN
these_DT
conditions_NNS
,_,
about_RB
0.5_CD
%_NN
of_IN
47.10_CD
cells_NNS
formed_VBD
large_JJ
14-day_JJ
colonies_NNS
-LRB-_-LRB-
&gt;_JJR
1_CD
mm_NN
-RRB-_-RRB-
composed_VBN
of_IN
mature_JJ
monocytes_NNS
and_CC
granulocytes_NNS
,_,
reflecting_VBG
the_DT
presence_NN
of_IN
progenitors_NNS
endowed_JJ
with_IN
high_JJ
proliferative_JJ
potential_NN
-LRB-_-LRB-
HPP-47_NN
.10_CD
cells_NNS
-RRB-_-RRB-
._.

In_IN
conclusion_NN
,_,
we_PRP
have_VBP
characterized_VBN
a_DT
novel_JJ
continuous_JJ
myeloid_JJ
cell_NN
line_NN
presenting_VBG
a_DT
hierarchical_JJ
structure_NN
similar_JJ
to_TO
that_DT
of_IN
the_DT
bone_NN
marrow_NN
progenitor_NN
cell_NN
compartment_NN
._.

